Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
diabetic retinopathy/edema
L'enllaç es desa al porta-retalls
Pàgina 1 des de 253 resultats
OCTA Metrics Repeatability and Reproducibility in Different Disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This will be prospective cross-sectional study. This research will be done in the period between 1 August and 31 December 2020 and will include 80 eyes from patients with following disorders:
Group 1: Patients with diabetic retinopathy Group 2: Patients with myopia Group 3: patients with choroidal
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Primary Objective: To investigate ranibizumab's benefit on prevention of early postoperative vitreous haemorrhage in PDR-DME patients receiving vitrectomy.
Secondary Objective:To investigate ranibizumab's additional benefit on visual improvement, facilitation of surgery and postoperative outcomes in
Advanced Glycation End Products Are Associated With Diabetic Macular Edema
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This was a cross-sectional study was carried out in the Hacettepe University Hospital, Department of Ophthalmology, between July 2018 and February 2019.
While benefiting from the results of the previous studies, the sample size of the research was type 1 error level α = 0.05 and type 2 level β =
ADVM-022 Intravitreal Gene Therapy for DME
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
ADVM-022 (AAV.7m8-aflibercept) is a gene therapy product developed for the treatment of serious retinal vascular diseases including Diabetic Macular Edema (DME). DME affects up to 10% of people with diabetes is caused by fluid accumulation in the macula and is the most frequent cause of sight loss
Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Pathogenesis of diabetic macular edema (DME) involves inflammation, angiogenesis, and oxidative stress processes provoked mainly by cytokines such as interleukin (IL)-6, 8, and monocyte chemotactic protein, and vascular endothelial growth factor (VEGF). Vision loss associated with diabetic
Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This prospective, open-label, single-center, randomized, fellow-eye, investigator-sponsored clinical study seeks to investigate the incidence of PME in diabetic patients with any level of background diabetic retinopathy undergoing cataract surgery treated with a 0.4mg dexamethasone intracanalicular
SD-OCT Measurement of the Human Retina in Pregnancy With Pre-existing or De Novo Hypertension and Without Hypertension
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This is a prospective observational cohort study that was undertaken at Foothills Medical Centre, University of Calgary, Calgary, Canada. Recruitment began in October 2013 and clinical follow-ups completed in May 2017.
Data was collected at enrolment (< 20 weeks gestation), at every follow-up
Pancreatic Islet Transplantation to the Anterior Chamber of the Eye
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Type 1 diabetes (T1D) is caused by the destruction of pancreatic islet cells through an autoimmune attack against insulin-producing beta cells in the endocrine pancreas. This in turn impairs glucose control causing multi-organ failure, morbidity and mortality which are also associated with high
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Arterial Composition and Cardiovascular Outcome in DIabeteS
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
PhD project description
The arterial wall in patients with diabetes: Do changes in arterial basement membrane proteins predict future arterial disease? Are remodeling processes altered?
Applicant: Anne-Sofie Faarvang Thorsen1, MD
Main supervisor: Professor Lars Melholt Rasmussen1
Co-supervisors:
Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The investigator study compare the effect of lipid lowering agent on the enhancement of visual acuity and on reduction of macular edema in patients with diabetic retinopathy and also compare their effect on reduction of cardiovascular risk on diabetic patients via assessment of ASCVD risk score
Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
interventional observational study comparing vitrectomy with versus without internal limiting membrane peeling in cases of rhegmatogenous retinal detachment.
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
